Searched for
INVAGEN PHARMACEUTICALS INC
Cipla unit recalls one lot of medication in US due to seal integrity issueDrug major Cipla's subsidiary is voluntarily recalling one lot of medication in the US due to seal integrity issues. InvaGen Pharmaceutical...- Cipla unit gets notice from US firm for termination of acquisition deal"Since the second stage closing could not be completed as per the agreed timelines, in the terms of the SPMA, InvaGen has received a notice...
- Samurai sunrise: Japanese bank MUFG is the new go-to financier for who's who of India IncFor once, India's favourite bankroller is not a Wall Street bank, nor a Swiss or a blueblooded British one.
- Cipla's subsidiary to acquire US-based Avenue Therapeutics for $ 215 millionAt the second stage, InvaGen or its affiliates will acquire the remaining shares of Avenue's common stock, for up to USD 180 million in the...
- Cipla gets USFDA nod for generic version of Renvela tabletsThe approved product is a generic equivalent to the reference listed drug (RLD), Renvela tablets, 800 mg of Genzyme Corporation, said Cipla.
- Cipla gets USFDA nod for generic anti-depressant drugThe company's tablets are generic versions of Valeant's Wellbutrin XL tablets in the same strengths, Cipla said.
- Cipla's ratings unlikely to be impacted by US acquisitions: India RatingsIndia Ratings & Research today said Cipla's ratings are unlikely to be affected by the recent cash-rich acquisitions of two US-based compan...
- Post Invagen sale, Hetero says to strengthen US operationsCipla said the group, through its subsidiary Camber Pharmaceuticals Inc., will continue to strengthen its operations in the US.
- US FDA approves Glenmark's Nabumetone & Hydroxyzine HydrochlorideGlenmark Pharmaceuticals Inc, US a subsidiary of Glenmark Pharmaceuticals has initiated the marketing and distribution of Nabumetone tablet...
- Ranbaxy ties up with US coPharma major Ranbaxy Laboratories Ltd has entered into a strategic partnership with US-based Invagen Pharmaceuticals Inc.
Load More
